AKTX · CIK 0001541157 · operating
Akari Therapeutics Plc (AKTX) is a pharmaceutical preparations company incorporated in United Kingdom, listed on the Nasdaq. With a market capitalization of $12 million, Akari Therapeutics Plc is a micro-cap company. The stock currently trades at $0.24, up 0.70% today, with a 52-week range of $0.22–$1.73.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | — | |
| 2023 | $0.00 | $0.00 | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — |